Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Interleukin-12 (IL-12) is a potent immunotherapeutic agent.

Saved in:
Bibliographic Details
Main Authors: Pengju Wang, Xiaozhu Li, Jiwei Wang, Dongling Gao, Yuenan Li, Haoze Li, Yongchao Chu, Zhongxian Zhang, Hongtao Liu, Guozhong Jiang, Zhenguo Cheng, Shengdian Wang, Jianzeng Dong, Baisui Feng, Louisa S. Chard, Nicholas R. Lemoine, Yaohe Wang
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Science
Q
Online Access:https://doaj.org/article/84f37118338744888cbe6343b27f3c3f
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/84f37118338744888cbe6343b27f3c3f

Similar Items